230 related articles for article (PubMed ID: 37511766)
21. Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy.
Arrigo M; Truong QA; Szymonifka J; Rivas-Lasarte M; Tolppanen H; Sadoune M; Gayat E; Cohen-Solal A; Ruschitzka F; Januzzi JL; Singh JP; Mebazaa A
Europace; 2017 Nov; 19(11):1848-1854. PubMed ID: 28096288
[TBL] [Abstract][Full Text] [Related]
22. CT-IGFBP-4 as a novel prognostic biomarker in acute heart failure.
Konev AA; Kharitonov AV; Rozov FN; Altshuler EP; Serebryanaya DV; Lassus J; Harjola VP; Katrukha AG; Postnikov AB
ESC Heart Fail; 2020 Apr; 7(2):434-444. PubMed ID: 31967738
[TBL] [Abstract][Full Text] [Related]
23. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study.
Wild PS; Schnabel RB; Lubos E; Zeller T; Sinning CR; Keller T; Tzikas S; Lackner KJ; Peetz D; Rupprecht HJ; Bickel C; Morgenthaler NG; Papassotiriou J; Tiret L; Münzel T; Blankenberg S
Clin Chem; 2012 Jan; 58(1):226-36. PubMed ID: 22065157
[TBL] [Abstract][Full Text] [Related]
24. Mid-regional pro-adrenomedullin and lactate levels for risk stratification in patients with out-of-hospital cardiac arrest.
Zelniker TA; Schwall D; Hamidi F; Steinbach S; Scheller P; Spaich S; Michels G; Giannitsis E; Katus HA; Frey N; Preusch MR
Eur Heart J Acute Cardiovasc Care; 2023 Jun; 12(6):364-371. PubMed ID: 36943296
[TBL] [Abstract][Full Text] [Related]
25. Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.
Düngen HD; Tscholl V; Obradovic D; Radenovic S; Matic D; Musial Bright L; Tahirovic E; Marx A; Inkrot S; Hashemi D; Veskovic J; Apostolovic S; von Haehling S; Doehner W; Cvetinovic N; Lainscak M; Pieske B; Edelmann F; Trippel T; Loncar G
ESC Heart Fail; 2018 Apr; 5(2):288-296. PubMed ID: 29476612
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort.
Funke-Kaiser A; Havulinna AS; Zeller T; Appelbaum S; Jousilahti P; Vartiainen E; Blankenberg S; Sydow K; Salomaa V
Ann Med; 2014 May; 46(3):155-62. PubMed ID: 24506434
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.
Montrucchio G; Sales G; Rumbolo F; Palmesino F; Fanelli V; Urbino R; Filippini C; Mengozzi G; Brazzi L
PLoS One; 2021; 16(2):e0246771. PubMed ID: 33556140
[TBL] [Abstract][Full Text] [Related]
28. Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.
Miller L; Chartrand S; Koenig M; Goulet JR; Rich É; Chin AS; Chartrand-Lefebvre C; Abrahamowicz M; Senécal JL; Grodzicky T
Scand J Rheumatol; 2014; 43(4):314-23. PubMed ID: 25089008
[TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
[TBL] [Abstract][Full Text] [Related]
31. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
[TBL] [Abstract][Full Text] [Related]
32. Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?
Spoto S; Basili S; Cangemi R; D'Avanzo G; Lupoi DM; Romiti GF; Argemi J; Yuste JR; Lucena F; Locorriere L; Masini F; Testorio G; Calarco R; Fogolari M; Francesconi M; Battifoglia G; Costantino S; Angeletti S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139258
[TBL] [Abstract][Full Text] [Related]
33. Circulating adrenomedullin and B-type natriuretic peptide do not predict blood pressure fluctuations during pheochromocytoma resection: a cross-sectional study.
Berends AMA; Buitenwerf E; Riphagen IJ; Lenders JWM; Timmers HJLM; Kruijff S; Links TP; van der Horst-Schrivers ANA; Stegeman CA; Eekhoff EMW; Feelders RA; Corssmit EPM; Groote Veldman R; Haak HR; Muller Kobold AC; Kerstens MN
Eur J Endocrinol; 2021 Aug; 185(4):507-514. PubMed ID: 34324433
[TBL] [Abstract][Full Text] [Related]
34. Biomarker guidance allows a more personalized allocation of patients for remote patient management in heart failure: results from the TIM-HF2 trial.
Möckel M; Koehler K; Anker SD; Vollert J; Moeller V; Koehler M; Gehrig S; Wiemer JC; von Haehling S; Koehler F
Eur J Heart Fail; 2019 Nov; 21(11):1445-1458. PubMed ID: 31129929
[TBL] [Abstract][Full Text] [Related]
35. Mid-regional pro-adrenomedullin: an indicator of the failing Fontan circuit in patients with univentricular hearts?
Kaiser R; Abdul-Khaliq H; Wilkens H; Herrmann E; Raedle-Hurst TM
Eur J Heart Fail; 2014 Oct; 16(10):1082-8. PubMed ID: 25201135
[TBL] [Abstract][Full Text] [Related]
36. GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome.
Kosum P; Siranart N; Mattanapojanat N; Phutinart S; Kongruttanachok N; Sinphurmsukskul S; Siwamogsatham S; Puwanant S; Ariyachaipanich A
BMC Cardiovasc Disord; 2024 Mar; 24(1):151. PubMed ID: 38475710
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress.
Sinning C; Ojeda F; Zeller T; Zengin E; Rupprecht HJ; Lackner KJ; Bickel C; Blankenberg S; Schnabel RB; Westermann D
Can J Cardiol; 2016 Dec; 32(12):1470-1477. PubMed ID: 27568502
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and Glomerular Filtration Rate in Patients With Acute Heart Failure.
Wang K; Ni G; Wu Q; Zhou Y; Yao W; Zhang H; Li X
Front Cardiovasc Med; 2020; 7():123. PubMed ID: 32793638
[No Abstract] [Full Text] [Related]
39. Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study.
Montrucchio G; Sales G; Balzani E; Lombardo D; Giaccone A; Cantù G; D'Antonio G; Rumbolo F; Corcione S; Simonetti U; Bonetto C; Zanierato M; Fanelli V; Filippini C; Mengozzi G; Brazzi L
Front Med (Lausanne); 2023; 10():1122367. PubMed ID: 37035317
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
